BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31210839)

  • 1. Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells.
    Chen K; Xu H; Zhao J
    Oxid Med Cell Longev; 2019; 2019():3685817. PubMed ID: 31210839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloom helicase explicitly unwinds 3'-tailed G4DNA structure in prostate cancer cells.
    Zhu XH; Sun BF; Luo M; Yu J; Zhang YD; Xu HQ; Luo H
    Int J Biol Macromol; 2021 Jun; 180():578-589. PubMed ID: 33727188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS
    PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diallyl trisulfide-induced prostate cancer cell death is associated with Akt/PKB dephosphorylation mediated by P-p66shc.
    Borkowska A; Sielicka-Dudzin A; Herman-Antosiewicz A; Wozniak M; Fedeli D; Falcioni G; Antosiewicz J
    Eur J Nutr; 2012 Oct; 51(7):817-25. PubMed ID: 22020565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.
    Nascimento EB; Snel M; Guigas B; van der Zon GC; Kriek J; Maassen JA; Jazet IM; Diamant M; Ouwens DM
    Cell Signal; 2010 Jun; 22(6):961-7. PubMed ID: 20138985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a Novel Bloom's Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer.
    Ma XY; Xu HQ; Zhao JF; Ruan Y; Chen B
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
    Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
    Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
    Chong Y; Xue L
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):29-40. PubMed ID: 33639053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
    Sun W; Zu S; Shao G; Wang W; Gong F
    J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.
    Malla R; Ashby CR; Narayanan NK; Narayanan B; Faridi JS; Tiwari AK
    Biochem Biophys Res Commun; 2015 Jul; 463(3):161-6. PubMed ID: 26003731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RecQ helicase BLM regulates prostate cancer cell proliferation and apoptosis.
    Qian X; Feng S; Xie D; Feng D; Jiang Y; Zhang X
    Oncol Lett; 2017 Oct; 14(4):4206-4212. PubMed ID: 28943928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.
    Höll M; Koziel R; Schäfer G; Pircher H; Pauck A; Hermann M; Klocker H; Jansen-Dürr P; Sampson N
    Mol Carcinog; 2016 Jan; 55(1):27-39. PubMed ID: 25559363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer.
    Votino C; Laudanna C; Parcesepe P; Giordano G; Remo A; Manfrin E; Pancione M
    J Gastroenterol; 2017 Mar; 52(3):327-340. PubMed ID: 27169843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PRAS40 in Akt and mTOR signaling in health and disease.
    Wiza C; Nascimento EB; Ouwens DM
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
    Yin Y; Sui C; Meng F; Ma P; Jiang Y
    Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis.
    Huang B; Porter G
    Acta Pharmacol Sin; 2005 Oct; 26(10):1253-8. PubMed ID: 16174443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
    Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
    Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.